Every enterprise AI leader faces this question: should we build custom AI or buy off-the-shelf? In life sciences, the stakes are higher because regulatory requirements, data sensitivity, and clinical workflow integration add complexity that doesn't exist in other industries.

The Build vs. Buy Framework

I use a simple decision matrix with four dimensions:

1. Competitive Differentiation

Does this AI capability create a strategic advantage unique to your organization? If yes, consider building. If it's a commodity capability (clinical documentation, medical coding, scheduling optimization), buy it. You don't gain competitive advantage from having a slightly better clinical notes summarizer.

2. Data Uniqueness

Do you have proprietary data that would make a custom model significantly better than a generic one? Large health systems with decades of EHR data, unique patient populations, or specialized clinical protocols may have data advantages that justify building. Most don't.

3. Integration Complexity

How deeply does the AI need to integrate with your existing systems? Shallow integrations (standalone tools, report generators) favor buying. Deep integrations (real-time EHR embedded workflows, clinical decision support at point of care) may favor building because vendor products often can't match your specific integration needs.

4. Regulatory Requirements

Does the AI require FDA clearance or other regulatory approval? If yes, buying from a vendor who already has clearance saves 12-24 months. Building means you own the regulatory burden - submission, post-market surveillance, adverse event reporting - forever.

The Real Costs of Building

Teams consistently underestimate build costs:

  • Data engineering: $200K-$500K - cleaning, labeling, and preparing training data
  • Model development: $200K-$500K - architecture, training, evaluation
  • Integration: $100K-$300K - connecting to EHR and clinical systems
  • Validation: $50K-$200K - clinical validation, bias testing, regulatory prep
  • Ongoing maintenance: $200K-$500K/year - retraining, monitoring, compliance updates

Total first-year cost: $750K-$1.5M. Total 3-year TCO: $1.2M-$3M+. Most organizations underestimate this by 50-100%.

The Real Costs of Buying

  • License fees: $50K-$500K/year depending on scale and vendor
  • Integration: $50K-$200K - connecting vendor to your systems
  • Customization: $25K-$100K - adapting to your specific workflows
  • Training: $10K-$50K - user adoption and change management

Total first-year cost: $135K-$850K. Total 3-year TCO: $285K-$1.7M.

The Hybrid Approach: Buy First, Build Later

The smartest strategy I've seen: buy commodity AI capabilities now while building internal AI competency. Use vendor products to learn the domain, understand user needs, and accumulate data. When you have enough expertise and proprietary data, build custom solutions for your 2-3 highest-value use cases.

Key Takeaways

  • Default to buy unless you have a clear competitive differentiation argument.
  • Build costs are 2-3x higher than initial estimates. Include maintenance, retraining, and compliance in your TCO.
  • Regulatory clearance is a massive build cost. If a vendor already has FDA clearance, you're buying 12-24 months of time.
  • Buy first, build later is the lowest-risk strategy. Learn before you invest.
  • Data is the moat, not the model. If you don't have unique, proprietary data, your custom model won't outperform vendor solutions.